306 related articles for article (PubMed ID: 18774009)
1. The role of electrophysiology study in risk stratification of sudden cardiac death.
Thomas KE; Josephson ME
Prog Cardiovasc Dis; 2008; 51(2):97-105. PubMed ID: 18774009
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive risk stratification for sudden death: signal-averaged electrocardiography, nonsustained ventricular tachycardia, heart rate variability, baroreflex sensitivity, and QRS duration.
Stein KM
Prog Cardiovasc Dis; 2008; 51(2):106-17. PubMed ID: 18774010
[No Abstract] [Full Text] [Related]
3. Sudden death risk in syncope: the role of the implantable cardioverter defibrillator.
Olshansky B; Sullivan RM
Prog Cardiovasc Dis; 2013; 55(4):443-53. PubMed ID: 23472783
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction: 14 years after MADIT.
Franqui-Rivera H; Sotomonte JC
P R Health Sci J; 2011 Jun; 30(2):78-83. PubMed ID: 21682151
[TBL] [Abstract][Full Text] [Related]
5. [Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment].
Serdoz LV; Fabris E; Lutman C; Merlo M; Zecchin M; Sinagra G
G Ital Cardiol (Rome); 2012 Sep; 13(9):592-601. PubMed ID: 22825344
[TBL] [Abstract][Full Text] [Related]
6. Screening and risk evaluation for sudden cardiac death in ischaemic and non-ischaemic cardiomyopathy: results of the European Heart Rhythm Association survey.
Proclemer A; Lewalter T; Bongiorni MG; Svendsen JH; Pison L; Lundqvist CB;
Europace; 2013 Jul; 15(7):1059-62. PubMed ID: 23794672
[TBL] [Abstract][Full Text] [Related]
7. [Risk stratification and prevention of sudden death in patients with heart failure].
Villacastín J; Bover R; Castellano NP; Moreno J; Morales R; García-Espinosa A
Rev Esp Cardiol; 2004 Aug; 57(8):768-82. PubMed ID: 15282066
[TBL] [Abstract][Full Text] [Related]
8. Screening and therapy for patients with nonsustained ventricular tachycardia.
Prystowsky EN
Am J Cardiol; 2000 Nov; 86(9A):34K-39K. PubMed ID: 11084098
[TBL] [Abstract][Full Text] [Related]
9. Cardiac magnetic resonance for risk stratification: the sudden death risk portrayed.
Villuendas R; Kadish AH
Prog Cardiovasc Dis; 2008; 51(2):128-34. PubMed ID: 18774012
[TBL] [Abstract][Full Text] [Related]
10. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
11. [Risk stratification in atrial and ventricular arrhythmias].
Fauchier L; Robin I; de Labriolle A; Poret P; Giraudeau C; Cosnay P; Babuty D
Ann Cardiol Angeiol (Paris); 2006 Jun; 55(3):127-34. PubMed ID: 16792027
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial.
Prystowsky EN; Nisam S
Am J Cardiol; 2000 Dec; 86(11):1214-5, A5. PubMed ID: 11090794
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
14. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
[TBL] [Abstract][Full Text] [Related]
15. [Limits and scopes of invasive risk stratification. Do we still need programmed ventricular stimulation?].
Rolf S; Haverkamp W
Herz; 2009 Nov; 34(7):528-38. PubMed ID: 20091252
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203
[TBL] [Abstract][Full Text] [Related]
17. [Is an electrophysiological study always necessary before defibrillator implantation?].
Bänsch D; Antz M
Herz; 2005 Mar; 30(2):119-22. PubMed ID: 15875100
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G
N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
[TBL] [Abstract][Full Text] [Related]
20. [Arrhythmias during remodeling after myocardial infarction].
Bauer WR; Ertl G
Herz; 2002 Dec; 27(8):740-9. PubMed ID: 12574891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
